ArticleNature communications2024

Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.

Anneke L Eerkens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.